Neonatal encephalopathy and hypoxic–ischemic encephalopathy

AJ Gunn, M Thoresen - Handbook of clinical neurology, 2019 - Elsevier
Acute hypoxic–ischemic encephalopathy around the time of birth remains a major cause of
death and life-long disability. The key insight that led to the modern revival of studies of …

Neonatal encephalopathy: beyond hypoxic-ischemic encephalopathy

JB Russ, R Simmons, HC Glass - Neoreviews, 2021 - publications.aap.org
Neonatal encephalopathy is a clinical syndrome of neurologic dysfunction that
encompasses a broad spectrum of symptoms and severity, from mild irritability and feeding …

The ILAE classification of seizures and the epilepsies: Modification for seizures in the neonate. Position paper by the ILAE Task Force on Neonatal Seizures

RM Pressler, MR Cilio, EM Mizrahi, SL Moshé… - …, 2021 - Wiley Online Library
Seizures are the most common neurological emergency in the neonatal period and in
contrast to those in infancy and childhood, are often provoked seizures with an acute cause …

Levetiracetam versus phenobarbital for neonatal seizures: a randomized controlled trial

C Sharpe, GE Reiner, SL Davis, M Nespeca… - …, 2020 - publications.aap.org
METHODS: The study was a multicenter, randomized, blinded, controlled, phase IIb trial
investigating the efficacy and safety of levetiracetam compared with phenobarbital as a first …

A machine-learning algorithm for neonatal seizure recognition: a multicentre, randomised, controlled trial

AM Pavel, JM Rennie, LS de Vries… - The Lancet Child & …, 2020 - thelancet.com
Background Despite the availability of continuous conventional electroencephalography
(cEEG), accurate diagnosis of neonatal seizures is challenging in clinical practice …

Safety of early discontinuation of antiseizure medication after acute symptomatic neonatal seizures

HC Glass, JS Soul, T Chang, CJ Wusthoff… - JAMA …, 2021 - jamanetwork.com
Importance Antiseizure medication (ASM) treatment duration for acute symptomatic neonatal
seizures is variable. A randomized clinical trial of phenobarbital compared with placebo after …

Profile of neonatal epilepsies: characteristics of a prospective US cohort

RA Shellhaas, CJ Wusthoff, TN Tsuchida, HC Glass… - Neurology, 2017 - AAN Enterprises
Objective: Although individual neonatal epilepsy syndromes are rare, as a group they
represent a sizable subgroup of neonatal seizure etiologies. We evaluated the profile of …

[HTML][HTML] Neonatal seizure management: is the timing of treatment critical?

AM Pavel, JM Rennie, LS de Vries, M Blennow… - The Journal of …, 2022 - Elsevier
Objective To assess the impact of the time to treatment of the first electrographic seizure on
subsequent seizure burden and describe overall seizure management in a large neonatal …

A pilot randomized, controlled, double‐blind trial of bumetanide to treat neonatal seizures

JS Soul, AM Bergin, C Stopp, B Hayes… - Annals of …, 2021 - Wiley Online Library
Objective In the absence of controlled trials, treatment of neonatal seizures has changed
minimally despite poor drug efficacy. We tested bumetanide added to phenobarbital to treat …

Neonatal presentation of genetic epilepsies: early differentiation from acute provoked seizures

MC Cornet, V Morabito, D Lederer, HC Glass… - …, 2021 - Wiley Online Library
Objective Although most seizures in neonates are due to acute brain injury, some represent
the first sign of neonatal onset genetic epilepsies. Delay in recognition and lack of expert …